FC
ONC

Financial Consulate’s BeOne Medicines Ltd ONC Stock Holding History

Financial Consulate’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.28K Buy
15
+9
+150% +$2.65K ﹤0.01% 880
2026
Q1 		$1.78K Buy
6
+3
+100% +$971 ﹤0.01% 998
2025
Q4 		$912 Buy
+3
New +$982 ﹤0.01% 1033

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Financial Consulate's ONC Position: Q2 2026 in Review

Financial Consulate increased its BeOne Medicines Ltd (ONC) stake by 150% in Q2 2026, buying an estimated $2.65K and bringing the position to 15 shares worth $4.28K. The position accounts for ﹤0.01% of the portfolio, ranked #880.

Financial Consulate first reported a position in ONC in Q4 2025 and has held it in 3 quarters since. 283 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Financial Consulate held 15 shares of BeOne Medicines Ltd worth $4.28K as of Q2 2026.
  • Financial Consulate bought 9 BeOne Medicines Ltd shares in Q2 2026, an estimated $2.65K.
  • BeOne Medicines Ltd made up ﹤0.01% of Financial Consulate's portfolio in Q2 2026, its #880 holding.
  • Financial Consulate first reported a position in BeOne Medicines Ltd in Q4 2025 and has held it in 3 quarters since.
  • 283 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Financial Consulate's 13F filing for Q2 2026, filed 23 Jul 2026.